Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.472 | 0.920 | 6 | 31575254 | upstream gene variant | G/A | snv | 0.12 | 0.14 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
|
0.600 | 0.680 | 6 | 31574705 | upstream gene variant | C/T | snv | 8.5E-02 |
|
0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.472 | 0.920 | 6 | 31575254 | upstream gene variant | G/A | snv | 0.12 | 0.14 |
|
Infections; Immune System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
0.851 | 0.200 | 6 | 31576412 | intron variant | A/G | snv | 7.1E-02 |
|
Infections; Immune System Diseases | 0.700 | 1.000 | 1 | 2009 | 2009 | |||||||
|
1.000 | 6 | 31575981 | intron variant | G/A | snv | 3.5E-02 |
|
0.700 | 1.000 | 2 | 2009 | 2010 | |||||||||
|
0.851 | 0.200 | 6 | 31576412 | intron variant | A/G | snv | 7.1E-02 |
|
0.700 | 1.000 | 2 | 2009 | 2010 | ||||||||
|
1.000 | 6 | 31578718 | downstream gene variant | G/C | snv | 3.5E-02 |
|
0.700 | 1.000 | 1 | 2009 | 2009 | |||||||||
|
0.472 | 0.920 | 6 | 31575254 | upstream gene variant | G/A | snv | 0.12 | 0.14 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
|
0.608 | 0.760 | 6 | 31574531 | upstream gene variant | T/C | snv | 0.19 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Respiratory Tract Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.472 | 0.920 | 6 | 31575254 | upstream gene variant | G/A | snv | 0.12 | 0.14 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Respiratory Tract Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
|
0.562 | 0.760 | 6 | 31575324 | upstream gene variant | G/A | snv | 4.6E-02 |
|
Immune System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.472 | 0.920 | 6 | 31575254 | upstream gene variant | G/A | snv | 0.12 | 0.14 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
0.472 | 0.920 | 6 | 31575254 | upstream gene variant | G/A | snv | 0.12 | 0.14 |
|
Stomatognathic Diseases | 0.020 | 1.000 | 2 | 2014 | 2016 | ||||||
|
0.701 | 0.480 | 6 | 31574699 | upstream gene variant | C/A | snv | 0.14 |
|
Stomatognathic Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.562 | 0.760 | 6 | 31575324 | upstream gene variant | G/A | snv | 4.6E-02 |
|
Stomatognathic Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.600 | 0.680 | 6 | 31574705 | upstream gene variant | C/T | snv | 8.5E-02 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.472 | 0.920 | 6 | 31575254 | upstream gene variant | G/A | snv | 0.12 | 0.14 |
|
Digestive System Diseases; Neoplasms | 0.010 | < 0.001 | 1 | 2016 | 2016 | ||||||
|
0.472 | 0.920 | 6 | 31575254 | upstream gene variant | G/A | snv | 0.12 | 0.14 |
|
Eye Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
0.701 | 0.480 | 6 | 31574699 | upstream gene variant | C/A | snv | 0.14 |
|
Eye Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.562 | 0.760 | 6 | 31575324 | upstream gene variant | G/A | snv | 4.6E-02 |
|
Eye Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.472 | 0.920 | 6 | 31575254 | upstream gene variant | G/A | snv | 0.12 | 0.14 |
|
Stomatognathic Diseases | 0.020 | 1.000 | 2 | 2014 | 2016 | ||||||
|
0.701 | 0.480 | 6 | 31574699 | upstream gene variant | C/A | snv | 0.14 |
|
Stomatognathic Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.562 | 0.760 | 6 | 31575324 | upstream gene variant | G/A | snv | 4.6E-02 |
|
Stomatognathic Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
1.000 | 6 | 31575981 | intron variant | G/A | snv | 3.5E-02 |
|
0.700 | 1.000 | 2 | 2009 | 2010 | |||||||||
|
0.851 | 0.200 | 6 | 31576412 | intron variant | A/G | snv | 7.1E-02 |
|
0.700 | 1.000 | 2 | 2009 | 2010 |